亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢康寶泰精細化工有限公司武昌一分部  

精細化學品,化工中間體,原料藥

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:付經理
  • 電話:027-87738651
  • QQ:664219562
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > ***度洛西汀原料
***度洛西汀原料
單價 1.00 / 千克對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 10000千克起訂1千克
品牌 湖北康寶泰
分子式 C18H20ClNOS
分子量 333.88
含量 99
過期 長期有效
更新 2014-06-25 12:28
 
詳細信息
分子式
中文名稱: ***度洛西汀
中文同義詞: (S)-(+)-N-甲基-3-(1-萘氧基)-3-(2-噻吩)-丙胺***;N-甲基-γ-(1-萘氧基)-2-噻吩丙胺***;度洛西汀***;消旋***度洛西汀;***度洛西汀;***度洛西汀 1.0 MG/ML;***度洛西汀雜質;度洛西林***
英文名稱: N-Methyl-gama-(1-naphthalenyloxy)-2-thiophenepropanamine
英文同義詞: (S)-DULOXETINE HYDROCHLORIDE;LY-248686;DULOXETINE HCL;DULOXETINE HYDROCHLORIDE;N-methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine, hydrochloride;(RS)Duloxetine HCl;(+)-(S)-N-Methyl-g-(1-naphthyloxy)-2-thiophenepropylamine;(gS)-N-Methyl-g-(1-naphthalenyloxy)-2-thiophenepropanamine
CAS號: 136434-34-9
分子式: C18H20ClNOS
分子量: 333.88
外觀:白色或類白色結晶性粉末干燥失重:≤0.5% ***化灰份:≤0.1% 重金屬:≤20PPm 比旋度:+118~+123o 含量(HPLC):≥99.0% 單個雜質:≤0.1 標準:USP ***度洛西汀介紹 ***度洛西汀 116817-11-9 含量(HPLC):≥99.0% CAS:116817-11-9; 136434-34-9 英文名:(RS)-Duloxetine hydrochloride 分子式:C18H19NOS?HCl 分子量:333.88 ***度洛西汀用途及工藝 用途:***度洛西汀腸溶膠囊包裝:25kg/紙板桶
©2025 武漢康寶泰精細化工有限公司武昌一分部 版權所有   技術支持:化工網   訪問量:26934  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |